Abstract
Herbal drugs for the prevention and treatment of various health disorders has been in practice a long time around the world. Generally the risk associated with herbal medicines is low, but some reports on serious reactions have been indicating the need of regulation and standards for these products. In this context, in the last five years, Brazilian Health Surveillance Agency (Anvisa) has been reframing some rules related to herbal medicines to assure quality, safety and efficacy of these products. Therefore, the aim of this review is to present a historical set of legislation in order to understanding the currently context of legal rules regarding herbal medicines, showing the progress of herbal medicine regulation in Brazil.
Get full access to this article
View all access options for this article.